GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Qingdao Vland Biotech Co Ltd (SHSE:603739) » Definitions » Preferred Dividends

Qingdao Vland Biotech Co (SHSE:603739) Preferred Dividends : ¥0 Mil (TTM As of Mar. 2024)


View and export this data going back to 2019. Start your Free Trial

What is Qingdao Vland Biotech Co Preferred Dividends?

Preferred dividend is a dividend that is accrued and paid on a company's preferred shares. Qingdao Vland Biotech Co's preferred dividends for the three months ended in Mar. 2024 was ¥0 Mil. Its preferred dividends for the trailing twelve months (TTM) ended in Mar. 2024 was ¥0 Mil.

Qingdao Vland Biotech Co Preferred Dividends Historical Data

The historical data trend for Qingdao Vland Biotech Co's Preferred Dividends can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Qingdao Vland Biotech Co Preferred Dividends Chart

Qingdao Vland Biotech Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Preferred Dividends
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Qingdao Vland Biotech Co Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Preferred Dividends Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Qingdao Vland Biotech Co Preferred Dividends Calculation

A dividend that is accrued and paid on a company's preferred shares.

Qingdao Vland Biotech Co  (SHSE:603739) Preferred Dividends Explanation

In the event that a company is unable to pay all dividends, claims to preferred dividends take precedence over claims to dividends that are paid on common shares.

Preferred Dividends for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥0 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Qingdao Vland Biotech Co (SHSE:603739) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Qingdao Vland Biotech Co Ltd (SHSE:603739) » Definitions » Preferred Dividends
Comparable Companies
SZSE:300147 SZSE:300583 SZSE:301166 SZSE:300878 SZSE:300404 SZSE:000504 SHSE:688137 SHSE:605177 SZSE:000710 SZSE:300238 OCSE:NOVO B VRTX REGN ASX:CSL SGEN XKRX:207940 MRNA HKSE:02269 XBRU:ARGX BNTX
Traded in Other Exchanges
N/A
Address
No. 1318, Wangsha Road, Room 108, Enterprise Service Center, Chengyang District, Shandong, Qingdao, CHN, 266061
Website
http://www.vlandgroup.com
Qingdao Vland Biotech Co Ltd is a biotechnology company. The company is engaged in research and development of four main product categories which are enzymes, probiotics, vaccines and animal health products.
Executives
Chen Gang Director
Jia De Qiang Director
Cao Cheng Director
Jiang Yong senior management
Xu Yong Supervisors

Qingdao Vland Biotech Co (SHSE:603739) Headlines

No Headlines